1 |
Smith, J. L., P. M. Fratamico, and N. W. Gunther. 2007. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog. Dis. 4: 134-163.
DOI
ScienceOn
|
2 |
Song, J. and S. Abraha. 2008. Innate and adaptive immune responses in the urinary tract. Eur. J. Clin. Invest. 38: 21-28.
DOI
ScienceOn
|
3 |
Wiles, T. J., R. R. Kulesus, and M. A. Mulvey. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85: 11-19.
DOI
ScienceOn
|
4 |
Wohlgemuth, S., D. Haller, M. Blaut, and G. Loh. 2009. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ. Microbiol. 11: 1562-1571.
DOI
ScienceOn
|
5 |
Xia, X., J. Meng, P. F. McDermott, and S. Zhao. 2011. Escherichia coli from retail meats carry genes associated with uropathogenic Escherichia coli, but are weakly invasive in human bladder cell culture. J. Appl. Microbiol. 110: 1166-1176.
DOI
ScienceOn
|
6 |
Yamamoto, S. 2007. Molecular epidemiology of uropathogenic Escherichia coli. J. Infect. Chemother. 13: 68-73.
DOI
|
7 |
Blango, M. G. and M. A. Mulvey. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54: 1855-1863.
DOI
ScienceOn
|
8 |
Clinical and Laboratory Standards Institute. 2004. Performance standards for antimicrobial susceptibility testing: Fourteenth informational supplement. M100-S14. National Committee for Clinical Laboratory Standards, Wayne, PA.
|
9 |
Albiger, B., S. Dahlberg, B. Henriques-Normark, and S. Normark. 2007. Role of the innate immune system in host defence against bacterial infections: Focus on the Toll-like receptors. J. Intern. Med. 261: 511-528.
DOI
ScienceOn
|
10 |
Anderson, G. G., K. W. Dodson, T. M. Hooton, and S. J. Hultgren. 2004. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12: 424-430.
DOI
ScienceOn
|
11 |
Farshad, S., R. Ranjbar, A. Japoni, M. Hosseini, M. Anvarinejad, and R. Mohammadzadegan. 2012. Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch. Iran. Med. 15: 312-316.
|
12 |
Iwasaki, A. and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
DOI
ScienceOn
|
13 |
Hancock, V., L. Ferrieres, and P. Klemm. 2007. Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol. Lett. 267: 30-37.
DOI
ScienceOn
|
14 |
Hilbert, D. W., K. E. Pascal, E. K. Libby, E. Mordechai, M. E. Adelson, and J. P. Trama. 2008. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide-and Toll-like receptor 4- independent pathway. Microbes Infect. 10: 114-121.
DOI
ScienceOn
|
15 |
Hornef, M. W., M. J. Wick, M. Rhen, and S. Normark. 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3: 1033-1040.
DOI
ScienceOn
|
16 |
Kau, A. L., D. A. Hunstad, and S. J. Hultgren. 2005. Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr. Opin. Microbiol. 8: 54-59.
DOI
ScienceOn
|
17 |
Jakobsen, L., P. Garneau, G. Bruant, J. Harel, S. Olsen, L. Porsbo, A. Hammerum, and N. Frimodt-Moller. 2012. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur. J. Clin. Microbiol. Infect. Dis. 31: 1121-1129.
DOI
ScienceOn
|
18 |
Jantausch, B. A., R. O'Donnell, and B. L. Wiedermann. 2000. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr. Nephrol. 15: 236-240.
DOI
|
19 |
Johnson, J. R., A. L. Stell, P. Delavari, A. C. Murray, M. Kuskowski, and W. Gaastra. 2001. Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J. Infect. Dis. 183: 897-906.
DOI
ScienceOn
|
20 |
Mulvey, M. A. 2002. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 4: 257-271.
DOI
ScienceOn
|
21 |
Mabbett, A. N., G. C. Ulett, R. E. Watts, J. J. Tree, M. Totsika, C. Y. Ong, et al. 2009. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int. J. Med. Microbiol. 299: 53-63.
DOI
ScienceOn
|
22 |
Marklund, B. I., J. M. Tennent, A. H. Garcia, M. Baga, F. Lindberg, W. Gaastra, and S. Normak. 1992. Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol. Microbiol. 6: 2225-2242.
DOI
ScienceOn
|
23 |
Martinez, J. J., M. A. Mulvey, J. D. Schilling, J. S. Pinkner, and S. J. Hultgren. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO. J. 19: 2803-2812.
DOI
ScienceOn
|
24 |
Mulvey, M. A., J. D. Schilling, and S. J. Hultgren. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69: 4572-4579.
DOI
ScienceOn
|
25 |
Schilling, J. D., S. M. Martin, D. A. Hunstad, K. P. Patel, M. A. Mulvey, S. S. Justice, et al. 2003. CD14- and Toll-like receptordependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect. Immun. 71: 1470- 1480.
DOI
|
26 |
Naves, P., G. del Prado, L. Huelves, M. Gracia, V. Ruiz, J. Blanco, et al. 2008. Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb. Pathog. 45: 86-91.
DOI
ScienceOn
|
27 |
Ngamwongsatit, P., P. P. Banada, W. Panbangred, and A. K. Bhunia. 2008. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J. Microbiol. Methods 73: 211-215.
DOI
ScienceOn
|
28 |
Ohkusa, T., T. Yoshida, N. Sato, S. Watanabe, H. Tajiri, and I. Okayasu. 2009. Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: A possible pathogenic mechanism of ulcerative colitis. J. Med. Microbiol. 58: 535-545.
DOI
ScienceOn
|
29 |
Russo, T. A. and J. R. Johnson. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: Focus on an increasingly important endemic problem. Microbes Infect. 5: 449-456.
DOI
ScienceOn
|
30 |
Scherberich, J. E. and A. Hartinger. 2008. Impact of Toll-like receptor signalling on urinary tract infection. Int. J. Antimicrob. Agents 31: 9-14.
DOI
ScienceOn
|
31 |
Schilling, J. D. and S. J. Hultgren. 2002. Recent advances into the pathogenesis of recurrent urinary tract infections: The bladder as a reservoir for uropathogenic Escherichia coli. Int. J. Antimicrob. Agents 19: 457-460.
DOI
ScienceOn
|
32 |
Schilling, J. D., M. A. Mulvey, C. D. Vincent, R. G. Lorenz, and S. J. Hultgren. 2001. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharidedependent mechanism. J. Immunol. 166: 1148-1155.
|
33 |
Sivick, K. E. and H. L. Mobley. 2010. Waging war against uropathogenic Escherichia coli: Winning back the urinary tract. Infect. Immun. 78: 568-585.
DOI
ScienceOn
|
34 |
Tiba, M. R., T. Yano, and D. S. Leite. 2008. Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev. Inst. Med. Trop. Sao Paulo 50: 255-260.
DOI
|
35 |
Wasteson, Y. 2001. Zoonotic Escherichia coli. Acta Vet. Scand. Suppl. 95: 79-84.
|
36 |
Soto, S., A. Smithson, J. Martinez, J. Horcajada, J. Mensa, and J. Vila. 2007. Biofilm formation in uropathogenic Escherichia coli strains: Relationship with prostatitis, urovirulence factors and antimicrobial resistance. J. Urol. 177: 365-368.
DOI
ScienceOn
|
37 |
Thompson, M. F., A. L. Litster, J. L. Platell, and D. J. Trott. 2011. Canine bacterial urinary tract infections: New developments in old pathogens. Vet. J. 190: 22-27.
DOI
ScienceOn
|
38 |
Van Houdt, R. and C. W. Michiels. 2005. Role of bacterial cell surface structures in Escherichia coli biofilm formation. Res. Microbiol. 156: 626-633.
DOI
ScienceOn
|